293 related articles for article (PubMed ID: 23370710)
21. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
Maheshwari A; Yoo HY; Thuluvath PJ
Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
24. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
26. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
Doycheva I; Zhang T; Amjad W; Thuluvath PJ
J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
[TBL] [Abstract][Full Text] [Related]
27. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
[TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
[TBL] [Abstract][Full Text] [Related]
30. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
[TBL] [Abstract][Full Text] [Related]
31. Liver Transplantation: East versus West.
Shukla A; Vadeyar H; Rela M; Shah S
J Clin Exp Hepatol; 2013 Sep; 3(3):243-53. PubMed ID: 25755506
[TBL] [Abstract][Full Text] [Related]
32. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
[TBL] [Abstract][Full Text] [Related]
33. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
[TBL] [Abstract][Full Text] [Related]
35. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
Wong RJ; Chou C; Bonham CA; Concepcion W; Esquivel CO; Ahmed A
Clin Transplant; 2014 Jun; 28(6):713-21. PubMed ID: 24654688
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
[TBL] [Abstract][Full Text] [Related]
37. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
[TBL] [Abstract][Full Text] [Related]
40. Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant.
Singal AK; Wong RJ; Jalan R; Asrani S; Kuo YF
Clin Transplant; 2021 Dec; 35(12):e14479. PubMed ID: 34510550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
